ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial - Concepedia

Concepedia

Publication | Open Access

ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial

DOI Full Paper Access

270

Citations

28

References

2009

Year

Massimo Federico, Stefano Luminari, Emilio Iannitto, Giuseppe Polimeno, Luigi Marcheselli, Antonella Montanini, Antonio La Sala, Francesco Merli, Caterina Stelitano, Samantha Pozzi,

Journal of Clinical Oncology

Abstract

As adopted in this study BEACOPP is associated with a significantly improved PFS compared with ABVD, with a predictable higher acute toxicity.

References

	Year	Citations

Page 1